X-Ray Systems in Massachusetts

Xingaoyi Medical Equipment Co., Ltd. is a National High-Tech enterprise headquartered in Yuyao City, Zhejiang Province, China. The company specializes in the design, manufacture, and distribution of advanced medical diagnostic and imaging equipment. Annual production capacity includes 200 units of Magnetic Resonance Imaging (MRI) systems (both superconductive and permanent magnet types), 100 units of Digital Radiography (DR) systems, and 50 units of Digital Radiology Fluoroscopy (DRF) systems. The company operates a provincial-level MRI research and development center, an enterprise postdoctoral workstation, and an academician workstation. Xingaoyi has undertaken high-tech industrialization projects for medical MRI systems under the National Development and Reform Commission (NDRC), the Torch Plan of the Ministry of Science and Technology, and National Science and Technology support initiatives. Product portfolio includes superconductive and permanent magnet MRI systems; suspended, pillar-mounted, and bone density measurement X-ray systems; integrated operating room solutions; and Magnetic Wave Knife technology. The company provides comprehensive support including technical assistance, market support, telemedicine capabilities, and equipment servicing with a commitment to 45-day contract completion. Distribution and service infrastructure extends globally, targeting county hospitals, regional medical centers, and healthcare systems seeking cost-effective diagnostic solutions.

VUNO Med, Inc. develops AI-driven diagnostic and patient monitoring software solutions for healthcare providers. The company manufactures two principal FDA-cleared products: VUNO Med®-DeepCARS®, an early warning system for cardiac arrest risk assessment in general ward inpatients using vital signs monitoring (heart rate, blood pressure, respiratory rate, oxygen saturation, plus age and timing); and VUNO Med®-Chest X-ray™ Triage, an AI-based diagnostic support system for detecting suspected chest abnormalities and major pulmonary diseases from chest radiography. Both products integrate deep learning algorithms with clinical workflows to assist healthcare professionals in reducing response times, lowering clinical costs, and improving patient outcomes. The DeepCARS system has been prospectively validated in multicentre studies published in peer-reviewed journals including Critical Care Medicine and Resuscitation, demonstrating predictive value for in-hospital cardiac arrest and unplanned ICU transfer. The Chest X-ray Triage system has undergone external validation for detection of nodular and reticular opacities in interstitial lung disease and other pulmonary conditions. VUNO distributes its solutions primarily to hospitals and health systems in the United States and maintains clinical advisory relationships with leading academic medical centers. The company emphasizes regulatory compliance and clinical evidence to support adoption in acute care settings.

Lunit International Limited is a healthcare AI software company specializing in cancer detection and precision oncology. Founded in 2013 with headquarters in Seoul and offices in Boston, the company develops clinically validated, FDA-cleared AI solutions that enhance cancer screening and treatment optimization. Lunit's modular ecosystem integrates imaging analysis, digital pathology, and biomarker intelligence across radiology, pathology, and oncology workflows. The platform serves over 10,000 customer sites across 65+ countries, with deployments focused on early detection in breast cancer, lung cancer, and personalized treatment selection through AI-powered biomarker analysis and immunohistochemistry quantification.